Systematic mutation screening and association study of the A1 and A(2a) adenosine receptor genes in panic disorder suggest a contribution of the A(2a) gene to the development of disease

Molecular Psychiatry

Volumn 3, Issue 1, 1998, Pages 81-85

  Deckert, J ^a,b   Nothen M M ^b   Franke, P ^b   Delmo, C ^b   Fritze, J ^c   Knapp, M ^b   Maier, W ^b   Beckmann, H ^a   Propping, P ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Adenosine A(2a) receptor; Adenosine A1 receptor; Association; Caffeine; Panic disorder; Polymorphism

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INTRON; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; PANIC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; SILENT GENE; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0031984203     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000345     Document Type: Article

References (23)

1. Boulenger JP, Uhde TW, Wolff EA, Post RM. Increased sensitivity to caffeine in patients with panic disorder: preliminary evidence. Arch Gen Psychiatry 1984; 40: 1067-1071.
2. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. American Psychiatric Association: Washington, DC, 1987.
3. Barraco RA, Jannsz CA, Schoener EP, Simpson LL. Cardiorespiratory function is altered by picomole injections of 5′-N-ethylcarboxamidoadenosine into the nucleus tractus solitarius of rats. Brain Res 1990; 507: 234-246.
4. Gorman JM, Fyer MR, Goetz R, Askanazi J, Liebowitz MR, Fyer AJ et al. Ventilalory physiology of patients with panic disorder. Arch Gen Psychiatry 1988; 45: 31-39.
5. Boulenger JP, Salem N, Marangos PJ, Uhde TW. Plasma adenosine levels: measurement in humans and relationship to the anxiogenic effects of caffeine. Psychiatry Res 1987; 21: 247-255.
6. Stein M, Black B, Brown TM, Uhde TW. Lack of efficacy of the adenosine reuptake inhibitor dipyridamole in the treatment of anxiety disorders. Biol Psychiatry 1993; 33: 647-650.
7. Williams M. Purinoceptors in central nervous system function. In: Bloom FE, Kupfer DJ (eds). Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York, NY, 1935, pp 643-655.
8. Noyes R, Crowe RR, Harris EL, Hamra BJ, McChesney CM, Chaudry DR. Relationship between panic disorder and agoraphobia. Arch Gen Psychiatry 1986; 43: 227-232.
9. Skre I, Onstad S, Torgersen S, Lygren S, Kringlen E. A twin study of DSM-III-R anxiety disorders. Acta Psychiatr Scand 1993; 88: 85-92.
10. Maier W, Lichtermann D, Minges J, Öhrlein A, Franke P. A controlled family study in panic disorder. J Psychiatr Res 1993; 27 (Suppl 1): 79-87.
11. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Panic disorder in women: a population-based twin study. Psychol Med 1993; 23: 397-406.
12. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
13. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265: 2037-2048.
14. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-513.
15. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-879.
16. 2a receptor. Nature 1997; 388: 674-678.
17. 2a adenosine receptor gene. J Neurochem 1996; 66: 363-368.
18. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J et al. The composite international diagnostic interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 1988; 45: 1069-1077.
19. Manuzza S, Fyer AJ, Klein DF, Endicott J. Schedule for Affective Disorders and Schizophrenia - Lifetime version (modified for the study of anxiety disorders): rationale and conceptual development. J Psychiatr Res 1986; 20: 317-325.
20. Ren H, Stiles GL. Characterization of the human A1 adenosine receptor gene. J Biol Chem 1994; 269: 3104-3110.
21. Le F, Townsend-Nicholson A, Baker E, Sutherland GR, Schofield PR. Characterization and chromosomal localization of the human A2a adenosine receptor gene: ADORA2A. Biochem Biophys Res Commun 1996; 223: 461-467.
22. 1 receptor gene. Systematic screening for DNA sequence variation and linkage mapping on chromosome 1q31-32.1 using a silent polymorphism in the coding region. Biochem Biophys Res Commun 1995; 214: 614-621.
23. 2aAR) gene: systematic mutation screening in patients with schizophrenia. J Neural Transm 1996; 103: 1447-1455.